Top compounds associated with response to L3MBTL1


Feature Type Standardized
Nominal ANOVA
mRNA azacitidine CTRPv2 pan-cancer AAC 0.086 0.02
mRNA Doxorubicin gCSI pan-cancer AAC -0.12 0.02
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.073 0.02
mRNA lapatinib CCLE pan-cancer AAC 0.1 0.02
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA CIL55A CTRPv2 pan-cancer AAC -0.11 0.03
mRNA AGK-2 CTRPv2 pan-cancer AAC 0.084 0.03
mRNA TAE684 CCLE pan-cancer AAC -0.1 0.03
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.08 0.03
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
Download CSV